DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Altoona, PA

7 verified pulmonary disease doctors in Altoona.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Pennsylvania State Board of Medicine

Dr. George Zlupko, MD

Pulmonary Disease

20 yrs NPPES
NPI 1902867716
800 CHESTNUT AVE, Altoona, PA 16601(814) 946-2846
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $74,304 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$74,304

Total received

135

Transactions

27

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$40,915
GlaxoSmithKline, LLC.$31,734
Regeneron Healthcare Solutions, Inc.$197.92
Mylan Specialty L.P.$137.73
Actelion Pharmaceuticals US, Inc.$125.23
Boehringer Ingelheim Pharmaceuticals, Inc.$117.83

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to George Zlupko do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Timothy Lucas, MD

Pulmonary Disease

20 yrs NPPES
NPI 1598723629
800 CHESTNUT AVENUE, ALTOONA LUNG SPECIALISTS, Altoona, PA 16601(814) 946-2846
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $2,634 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$2,634

Total received

123

Transactions

25

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$597.50
GlaxoSmithKline, LLC.$383.58
Regeneron Healthcare Solutions, Inc.$179.16
Actelion Pharmaceuticals US, Inc.$145.68
Mylan Specialty L.P.$137.72
Jazz Pharmaceuticals Inc.$126.90

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 88th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Timothy Lucas do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Craig Hartman, MD

Pulmonary Disease

20 yrs NPPES
NPI 1093764144
800 CHESTNUT AVE, ALTOONA LUNG SPECIALISTS, Altoona, PA 16601(814) 946-2846
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Rashmikant Pandit, MD

Pulmonary Disease

20 yrs NPPES
NPI 1922016559
1414 9TH AVE, STATION MEDICAL CENTER, Altoona, PA 16602(814) 946-1655
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Alan Kanouff, DO

Pulmonary Disease

19 yrs NPPES
NPI 1487787131
800 CHESTNUT AVE, Altoona, PA 16601(814) 946-2845
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $196,118 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$196,118

Total received

332

Transactions

29

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$97,822
GlaxoSmithKline, LLC.$89,228
Amgen Inc.$7,236
Bayer HealthCare Pharmaceuticals Inc.$216.88
Regeneron Healthcare Solutions, Inc.$211.01
Jazz Pharmaceuticals Inc.$102.51

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Alan Kanouff do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Mehrdad Ghaffari, MD

Pulmonary Disease

19 yrs NPPES
NPI 1770700718
1414 NINTH AVE, STATION MEDICAL CENTER, Altoona, PA 16602(814) 946-1655
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $1,362 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$1,362

Total received

3

Transactions

2

Paying companies

Top paying companies

Pulmonx Corporation$1,343
GlaxoSmithKline, LLC.$19.05

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 82th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Mehrdad Ghaffari do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Michael Zlupko, MD

Pulmonary Disease

19 yrs NPPES
NPI 1114121647
800 CHESTNUT AVE, Altoona, PA 16601(814) 946-2846
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $139,138 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$139,138

Total received

189

Transactions

26

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$107,846
Boehringer Ingelheim Pharmaceuticals, Inc.$13,262
Grifols USA, LLC$12,283
Insmed, Inc.$3,965
Grifols Shared Services North America, Inc.$540.00
AstraZeneca Pharmaceuticals LP$147.89

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 98% of that group — among the highest recipients.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Michael Zlupko do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Altoona, PA — Verified | DoctorsProof | DoctorsProof